MedPath

The effectiveness of propranolol in difficult to control blood pressure - a randomized trial

Phase 3
Conditions
Resistant hypertension
Registration Number
SLCTR/2016/002
Lead Sponsor
ational Research Council, Sri Lanka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

1. Age between 18-75 years

2. Resistant hypertension is defined as casual blood pressure during clinical examination of more than 140/90 mmHg (a mean of the 2nd and 3rd measurements during a single examination, at least 3 min apart) despite treatment with a multidrug combination consisting of a diuretic and ACEI/ARB, centrally acting drug, alpha blocker or calcium channel blocker

3. Blood pressure >140/90mmHg in patients below 60 years and >150/90mmHg if above 60 years

Exclusion Criteria

1. Systolic blood pressure > 220mmHg requiring immediate adjustments to therapy
2. Moderate to severe renal insufficiency (acute or chronic) with glomerular filtration rate of less than 30 ml/min ,
3. Active bronchospastic disorders
4. Heart failure class III and IV
5. Severe bradycardia(HR<50bpm)
6. AV block 2 and 3 degrees
7. Women who are lactating or pregnant ( a pregnancy test will be carried out during the initial examination)
8. History of hypersensitivity to any of the drugs under study
9. Current use of beta blockers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath